Bacterial disease and antimicrobial susceptibility patterns in HIV-infected, hospitalized children: a retrospective

Heather B Jaspan1, Lyen C Huang, Mark F Cotton

  • 1University of Cape Town School of Child and Adolescent Health, Cape Town, South Africa. heather.jaspan@sbri.org

Plos One
|September 25, 2008
PubMed
Abstract

Insights

Serious bacterial infections pose significant risks for children with HIV. Key pathogens like Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus are common, necessitating careful antibiotic selection in resource-limited settings.

Area of Science:

  • Pediatric Infectious Diseases
  • HIV/AIDS Research
  • Microbiology and Antimicrobial Resistance

Background:

  • Serious bacterial infections (SBIs) are a leading cause of illness and death in children with human immunodeficiency virus (HIV).
  • The types of bacteria causing SBIs and their resistance patterns vary by geographic location and healthcare setting.
  • Antibiotic prophylaxis and the rise of multi-drug resistant organisms (MDROs) in HIV-infected children require ongoing surveillance of causative agents and their antibiotic susceptibilities.

Purpose of the Study:

  • To identify common bacterial pathogens responsible for serious infections in hospitalized HIV-infected children.
  • To determine the antimicrobial susceptibility patterns of these pathogens.
  • To differentiate between community-acquired and hospital-acquired (nosocomial) infections.

Main Methods:

  • A retrospective cohort study was conducted on HIV-positive pediatric admissions at an urban public hospital in Cape Town from January 2002 to June 2006.
  • Included were children aged 1 month to 9 years with confirmed HIV, SBI, and hospitalization of at least 5 days.
  • Cultures from blood, urine, and cerebrospinal fluid were analyzed for organisms and their antibiotic susceptibility, comparing community- vs. hospital-acquired isolates.

Main Results:

  • 141 children were included (median age 1.2 years); 39% received antiretroviral therapy.
  • Pneumonia was the most frequent infection (67%), affecting all organ systems.
  • Common pathogens included Streptococcus pneumoniae, Staphylococcus aureus (all methicillin-resistant), and Klebsiella pneumoniae (all nosocomial and resistant to multiple antibiotics).

Conclusions:

  • Bacterial infections significantly contribute to co-morbidity in HIV-infected children, particularly in resource-limited areas.
  • Healthcare providers should maintain a low threshold for initiating antibiotics in hospitalized children with suspected infections.
  • Empirical antibiotic choices for serious bacterial infections in HIV-infected children should consider prevalent organisms and local antimicrobial resistance patterns, using broad-spectrum agents judiciously.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...